Milwaukee, Wisconsin 53201


Acute pain management following major surgical procedures in pediatric patients continues to be a challenge, especially after extensive posterior spine fusions. Spine surgery is particularly traumatic, initiating pain in both peripheral and central pathways. While the standard management of post-surgical pain involves a multimodal approach, opioids provide the predominant benefit. However, opioid use is associated with many adverse effects, including nausea, constipation, and pruritus. Perioperative methadone may decrease total opioid consumption and adverse effects as well as improve satisfaction with pain management after scoliosis repair.

Study summary:

This study is a double blind comparison, evaluating the benefits of intraoperative methadone in extensive posterior spine fusion surgery for idiopathic scoliosis. Methadone 0.2 mg/kg will be given to the treatment group. Postoperative evaluation for narcotic use, pain control, and adverse effects will be compared to a standard treatment approach used at Children's Hospital of Wisconsin.


Inclusion Criteria: - Age 10-18 years - Idiopathic scoliosis - Fusion levels planned for 10 or greater - English speaking - American Society of Anesthesiology (ASA) class 1 - 3 Exclusion Criteria: - Current narcotic use / History of substance abuse - Morphine, hydromorphone or methadone allergies - Pregnancy - Seizure Disorders - Bleeding disorders - Non-English speaking



Primary Contact:

Study Chair
Steven Weisman, MD
Children's Hospital and Health System Foundation, Wisconsin

Keri Hainsworth, PhD
Phone: 414266-6306

Backup Contact:

Ellen Edwards, BS

Location Contact:

Milwaukee, Wisconsin 53201
United States

Roger A Fons, MD
Phone: 414-266-3561

Site Status: Recruiting

Data Source:

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.